Galderma unveils seven-year partnership with Mount Sinai and Northwestern in atopic dermatitis. Beacon/Takeda and Zealand/UniQuest tie-ups both address gastrointestinal diseases.

A review of biopharma start-up deal-making and financing activity from July through September 2017, based on data from Strategic Transactions, showed that fundraising declined 18% from the previous quarter, however the number of acquisitions doubled to eight.

Now providing seed and venture funding for some of its start-ups, University of Maryland's tech transfer has expanded its capabilities in recent years. Plus, our monthly roundup of private/public-sector transactions.

Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.